HuGE Literature Finder
Records
1
-
2
Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model. Thrombosis journal 2013 11 (1): 14. Nshimyumukiza Léon, Duplantie Julie, Gagnon Mathieu, Douville Xavier, Fournier Diane, Lindsay Carmen, Parent Marc, Milot Alain, Giguère Yves, Gagné Christian, Rousseau François, Reinharz Dani |
A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data. Clinical medicine & research 2005 Aug 3 (3): 137-45. Hillman Michael A, Wilke Russell A, Yale Steven H, Vidaillet Humberto J, Caldwell Michael D, Glurich Ingrid, Berg Richard L, Schmelzer John, Burmester James |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 20, 2022
- Content source: